Vote for your favorite mineral in #MinCup25! - Jeremejevite vs. Haüyne
Are you ready for a battle of the blues? In a match of newcomers, volcanic gem hauyne is taking on rare jeremejevite.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

Trudel, Suzanne, Stewart, A. Keith (2024) A Belantamab Mafodotin Revival in Multiple Myeloma Therapy. New England Journal of Medicine, 391 (5) 461-462 doi:10.1056/nejme2406799

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleA Belantamab Mafodotin Revival in Multiple Myeloma Therapy
JournalNew England Journal of Medicine
AuthorsTrudel, SuzanneAuthor
Stewart, A. KeithAuthor
Year2024 (August)Volume391
Page(s)461-462Issue5
PublisherMassachusetts Medical Society
DOIdoi:10.1056/nejme2406799Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID17522035Long-form Identifiermindat:1:5:17522035:1
GUID0
Full ReferenceTrudel, Suzanne, Stewart, A. Keith (2024) A Belantamab Mafodotin Revival in Multiple Myeloma Therapy. New England Journal of Medicine, 391 (5) 461-462 doi:10.1056/nejme2406799
Plain TextTrudel, Suzanne, Stewart, A. Keith (2024) A Belantamab Mafodotin Revival in Multiple Myeloma Therapy. New England Journal of Medicine, 391 (5) 461-462 doi:10.1056/nejme2406799
In(2024, August) New England Journal of Medicine Vol. 391 (5) Massachusetts Medical Society

See Also

These are possibly similar items as determined by title/reference text matching only.

(2024) Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. New England Journal of Medicine, 391 (14). doi:10.1056/nejmc2410841
Dimopoulos, Meletios Athanasios, Beksac, Meral, Pour, Ludek, Delimpasi, Sosana, Vorobyev, Vladimir, Quach, Hang, Spicka, Ivan, Radocha, Jakub, Robak, Pawel, Kim, Kihyun, Cavo, Michele, Suzuki, Kazuhito, Morris, Kristin, Pompilus, Farrah, Phillips-Jones, Amy, Zhou, Xiaoou L., Fulci, Giulia, Sule, Neal, Kremer, Brandon E., Opalinska, Joanna, Mateos, María-Victoria, Trudel, Suzanne (2024) Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma. New England Journal of Medicine, 391 (5) 408-421 doi:10.1056/nejmoa2403407
Stewart, Dane, Thomas, Laura (2024) Intrathoracic Migration of a Breast Implant. New England Journal of Medicine, 391 (5) doi:10.1056/nejmicm2311298
Salmasi, Giselle, Murray, David L., Padmanabhan, Anand (2024) Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance. New England Journal of Medicine, 391 (6) 570-571 doi:10.1056/nejmc2406453
(2024) Myelodysplasia after Lentiviral Gene Therapy. New England Journal of Medicine, 391 (24). doi:10.1056/nejmc2414069
Stewart, Elizabeth A., Laughlin-Tommaso, Shannon K. (2024) Uterine Fibroids. New England Journal of Medicine, 391 (18). doi:10.1056/nejmcp2309623
Benjamin, Robert S. (2024) A Late-Arriving but Welcome Advance in Sarcoma Therapy. New England Journal of Medicine, 391 (9). doi:10.1056/nejme2407116
Terrault, Norah (2024) Treatment of Hepatitis D — A Future Role for Combination Therapy. New England Journal of Medicine, 391 (2) 181-183 doi:10.1056/nejme2406180
(2024) CD7 CAR T-Cell Therapy and Allogeneic HSCT. New England Journal of Medicine, 391 (1) 92-93 doi:10.1056/nejmc2406366
Yan, Wenhai (2024) Galeazzi Fracture. New England Journal of Medicine, 391 (5) doi:10.1056/nejmicm2402220
Hsu, Charles, Konner, Jason A., Gounder, Mrinal M. (2024) Epigenetic Therapy in a Rare Ovarian Cancer — A Double-Edged Sword. New England Journal of Medicine, 391 (8). doi:10.1056/nejmc2407971
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 3, 2025 22:52:28
Go to top of page